AR079170A1 - Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par - Google Patents
Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio parInfo
- Publication number
- AR079170A1 AR079170A1 ARP100104417A ARP100104417A AR079170A1 AR 079170 A1 AR079170 A1 AR 079170A1 AR P100104417 A ARP100104417 A AR P100104417A AR P100104417 A ARP100104417 A AR P100104417A AR 079170 A1 AR079170 A1 AR 079170A1
- Authority
- AR
- Argentina
- Prior art keywords
- imidazo
- prepare
- pharmaceutical composition
- treatment
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Compuesto derivado de ciclopropil-benzamida-imidazo-benzazepina, inhibidor de diacilglicerol aciltransferasa, de la formula (1) o una sal farmacéuticamente aceptante del mismo; en donde R1 se selecciona del grupo que consiste en H, F, Cl, -CF3, -CH3, -OH, -O(alquilo C1-4), -O-ciclopropilo, -O-CH2-fenilo, -OC(H)F2, y -OCF3; R2 se selecciona del grupo que consta de H y -CH3; R3 se selecciona del grupo que consiste en H y -CH3; con la condicion de que al menos uno del grupo que consta de R2 y R3 sea H; y n es 1, 2 o 3. Composicion farmacéutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina en un mamífero. Compuesto intermedio de imidazo-benzazepina para su síntesis de formula (2).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28531709P | 2009-12-10 | 2009-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR079170A1 true AR079170A1 (es) | 2011-12-28 |
Family
ID=43569741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104417A AR079170A1 (es) | 2009-12-10 | 2010-11-30 | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par |
Country Status (14)
Country | Link |
---|---|
US (1) | US8299061B2 (es) |
EP (1) | EP2509981B1 (es) |
JP (1) | JP5631411B2 (es) |
KR (1) | KR101395428B1 (es) |
CN (1) | CN102666543B (es) |
AR (1) | AR079170A1 (es) |
AU (1) | AU2010328410B2 (es) |
BR (1) | BR112012013918A2 (es) |
CA (1) | CA2783684C (es) |
EA (1) | EA020128B1 (es) |
ES (1) | ES2509922T3 (es) |
MX (1) | MX2012006646A (es) |
TW (1) | TWI392680B (es) |
WO (1) | WO2011071840A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
MY167881A (en) | 2010-07-16 | 2018-09-26 | Abbvie Bahamas Ltd | Process for preparing antiviral compounds |
MX338725B (es) | 2010-07-16 | 2016-04-28 | Abbvie Bahamas Ltd | Ligando de fosfina para reacciones cataliticas. |
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
WO2015120610A1 (en) * | 2014-02-14 | 2015-08-20 | Eli Lilly And Company | Gpr142 agonist compound |
CN105153195B (zh) * | 2015-09-01 | 2017-09-26 | 汤文建 | 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途 |
AU2020285269B2 (en) * | 2019-05-31 | 2022-11-17 | Medshine Discovery Inc. | Bicyclic compound as RIP-1 kinase inhibitor and application thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847248A (en) | 1986-12-23 | 1989-07-11 | Merck & Co., Inc. | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
EP0272866A1 (en) | 1986-12-23 | 1988-06-29 | Merck & Co. Inc. | 1,4-Benzodiazepines with 5-membered heterocyclic rings |
US4735941A (en) | 1986-12-23 | 1988-04-05 | Merck & Co., Inc. | 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents |
IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them |
EP0523846A3 (en) | 1991-06-14 | 1993-03-17 | Merck & Co. Inc. | 1,4-benzodiazepines with 5-membered heterocyclic rings |
US5439906A (en) | 1993-11-22 | 1995-08-08 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
DE69428546T2 (de) * | 1993-11-22 | 2002-04-11 | Merck & Co Inc | 3-acylaminobenzazepine |
JP2840454B2 (ja) | 1993-11-22 | 1998-12-24 | メルク エンド カンパニー インコーポレーテッド | ベンゾジアゼピン類 |
US5834464A (en) | 1994-11-18 | 1998-11-10 | Merck & Co., Inc. | Imidazolinobenzodiazepines |
CN1171878C (zh) | 1996-12-23 | 2004-10-20 | 伊兰药品公司 | 化合物、其用途以及含有所述化合物的药物组合物 |
GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
CA2577060A1 (en) * | 2004-08-13 | 2006-02-23 | Amgen Inc. | Substituted benzofused heterocycles |
DE602006009095D1 (en) * | 2005-05-10 | 2009-10-22 | Via Pharmaceuticals Inc | Diacylglycerol-acyltransferase-hemmer |
CA2615463A1 (en) | 2005-07-29 | 2007-02-08 | Merck & Co., Inc. | Heterocyclic benzodiazepine cgrp receptor antagonists |
US7569590B2 (en) | 2006-09-19 | 2009-08-04 | Bristol-Myers Squibb Company | Use of thianecarboxamides as dgat inhibitors |
US8394823B2 (en) | 2008-04-11 | 2013-03-12 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as DGAT1 inhibitors |
WO2009126624A1 (en) | 2008-04-11 | 2009-10-15 | Bristol-Myers Squibb Company | Triazolo compounds useful as dgat1 inhibitors |
JP2010116364A (ja) * | 2008-11-14 | 2010-05-27 | Banyu Pharmaceut Co Ltd | アゼピノン誘導体 |
EP2389366A1 (en) | 2009-01-23 | 2011-11-30 | Msd K.K. | Benzodiazepin-2-on derivatives |
WO2010095766A1 (en) | 2009-02-17 | 2010-08-26 | Banyu Pharmaceutical Co.,Ltd. | 1,4-benzodiazepin-2-on derivatives |
-
2010
- 2010-11-30 AR ARP100104417A patent/AR079170A1/es not_active Application Discontinuation
- 2010-12-02 TW TW099141941A patent/TWI392680B/zh not_active IP Right Cessation
- 2010-12-07 BR BR112012013918A patent/BR112012013918A2/pt not_active IP Right Cessation
- 2010-12-07 CA CA2783684A patent/CA2783684C/en not_active Expired - Fee Related
- 2010-12-07 US US12/961,714 patent/US8299061B2/en not_active Expired - Fee Related
- 2010-12-07 MX MX2012006646A patent/MX2012006646A/es unknown
- 2010-12-07 ES ES10799154.9T patent/ES2509922T3/es active Active
- 2010-12-07 EA EA201200868A patent/EA020128B1/ru not_active IP Right Cessation
- 2010-12-07 EP EP10799154.9A patent/EP2509981B1/en not_active Not-in-force
- 2010-12-07 KR KR1020127014795A patent/KR101395428B1/ko not_active IP Right Cessation
- 2010-12-07 WO PCT/US2010/059158 patent/WO2011071840A1/en active Application Filing
- 2010-12-07 JP JP2012543187A patent/JP5631411B2/ja not_active Expired - Fee Related
- 2010-12-07 CN CN201080055334.9A patent/CN102666543B/zh not_active Expired - Fee Related
- 2010-12-07 AU AU2010328410A patent/AU2010328410B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR20120099457A (ko) | 2012-09-10 |
US8299061B2 (en) | 2012-10-30 |
JP2013513607A (ja) | 2013-04-22 |
CA2783684A1 (en) | 2011-06-16 |
CN102666543B (zh) | 2014-12-24 |
JP5631411B2 (ja) | 2014-11-26 |
EA201200868A1 (ru) | 2012-12-28 |
EP2509981B1 (en) | 2014-08-06 |
EA020128B1 (ru) | 2014-08-29 |
AU2010328410A1 (en) | 2012-07-26 |
EP2509981A1 (en) | 2012-10-17 |
MX2012006646A (es) | 2012-06-25 |
WO2011071840A1 (en) | 2011-06-16 |
CN102666543A (zh) | 2012-09-12 |
AU2010328410B2 (en) | 2014-02-06 |
TWI392680B (zh) | 2013-04-11 |
US20110144091A1 (en) | 2011-06-16 |
KR101395428B1 (ko) | 2014-05-14 |
CA2783684C (en) | 2014-02-25 |
BR112012013918A2 (pt) | 2016-04-26 |
ES2509922T3 (es) | 2014-10-20 |
TW201130844A (en) | 2011-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR079170A1 (es) | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par | |
AR078522A1 (es) | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis | |
AR064736A1 (es) | Agonistas de gpcr | |
AR077638A1 (es) | Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad | |
AR071187A1 (es) | Compuesto de arilmetil-tiazinamina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento de la enfermedad de alzheimer | |
CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
CL2010001368A1 (es) | Compuestos derivados de 1,3-tiazina; composicion farmaceutica que lo comprende; utiles para inhibir a la beta-secretasa | |
UY32490A (es) | Inhibidores de beta-secretasa | |
AR086254A1 (es) | Derivados de imidazol utiles para el tratamiento de artritis | |
AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
AR065806A1 (es) | Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea. | |
ECSP13012755A (es) | Composiciones farmacéuticas que contienen un inhibidor de dgat1 | |
AR077277A1 (es) | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer | |
BRPI0817096A8 (pt) | Análogo de tiazolidinodiona e composição farmacêutica que o compreende | |
SV2011003903A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes | |
CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
PE20171255A1 (es) | Forma cristalina y amorfa de hemitartrato de genz 112638 como inhibidor de glucosilceramida sintasa | |
AR081819A1 (es) | Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades | |
UY33241A (es) | ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?. | |
EA201270216A1 (ru) | Фармацевтический состав | |
UY32062A (es) | Inhibidores de beta-secretasa | |
BRPI1013821A8 (pt) | piridinas substituídas como antagonistas de ccr3. | |
UY31863A (es) | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar | |
CO6710904A2 (es) | Formulación farmaceútica para inhibir la hipermeabilidad vascular en un ánimal | |
AR061134A1 (es) | Derivados de tioxantina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |